Draco investors report 0% stake in Bioceres Crop Solutions (BIOX)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Bioceres Crop Solutions Corp. received an updated ownership filing from the Draco group of investors. In this Amendment No. 2 to a Schedule 13G, DRACO I SPC LTD, DRACO Capital Investment Management Company Ltd, and DRACO I EVENT OPPORTUNITY SEGREGATED PORTFOLIO each report beneficial ownership of 0 ordinary shares, or 0.0% of Bioceres’ outstanding ordinary shares.
The Draco entities state they have no sole or shared power to vote or dispose of any Bioceres shares and confirm they now own 5 percent or less of the class. They also certify that any securities previously held were not acquired to change or influence control of Bioceres.
Positive
- None.
Negative
- None.
FAQ
What does the latest Schedule 13G/A filing say about Draco’s BIOX ownership?
The amended Schedule 13G shows the Draco entities now report 0 Bioceres ordinary shares, representing 0.0% of the class. This signals they no longer hold a reportable stake above 5% in Bioceres Crop Solutions Corp.
Which Draco entities are included in the Bioceres (BIOX) Schedule 13G/A?
The filing covers DRACO I SPC LTD, DRACO Capital Investment Management Company Ltd, and DRACO I EVENT OPPORTUNITY SEGREGATED PORTFOLIO. Each reports 0 shares and 0.0% beneficial ownership of Bioceres ordinary shares.
What percentage of Bioceres (BIOX) does Draco now own according to the amendment?
The amendment states each Draco reporting person owns 0.0% of Bioceres’ ordinary shares. This confirms they have ceased to be beneficial owners of more than five percent of the company’s outstanding common stock.
Why was Amendment No. 2 to the Bioceres (BIOX) Schedule 13G filed?
Amendment No. 2 updates beneficial ownership information to reflect that each Draco reporting person has reduced its holdings to 0 shares and 0.0%, and now owns 5 percent or less of Bioceres’ ordinary shares.
Does Draco intend to influence control of Bioceres Crop Solutions (BIOX)?
The certification states the securities referenced were not acquired and are not held for the purpose of changing or influencing control of Bioceres, other than activities solely related to a nomination under the applicable proxy rule.